Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • From nonalcoholic steatohepati...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials

Bibliographic Details
Main Authors: Ming-Lun Yeh, Ming-Lung Yu
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2023-10-01
Series:Clinical and Molecular Hepatology
Subjects:
nafld
mafld
sld
masld
steatosis
Online Access:http://e-cmh.org/upload/pdf/cmh-2023-0359.pdf
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://e-cmh.org/upload/pdf/cmh-2023-0359.pdf

Similar Items

  • Comparing similarities and differences between NAFLD, MAFLD, and MASLD in the general U.S. population
    by: Haoxuan Zou, et al.
    Published: (2024-07-01)
  • Endothelial dysfunction and cardiovascular risk in non-alcoholic fatty liver disease – a systematic review and meta-analysis
    by: Nilesh Toke, et al.
    Published: (2024-05-01)
  • Navigating the Nomenclature of Liver Steatosis: Transitioning from NAFLD to MAFLD and MASLD - Understanding Affinities and Differences
    by: Apichat Kaewdech, et al.
    Published: (2024-04-01)
  • Prevalence of steatotic liver disease (MASLD, MetALD, ALD) and clinically significant fibrosis in US adolescents
    by: Guang-Xia Shi, et al.
    Published: (2024-10-01)
  • Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan
    by: Chung-Feng Huang, et al.
    Published: (2024-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs